S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis

Prefrontal cortex (Brodmann's area 9) levels of the methyl donor S-adenosyl methionine were increased by about two-fold in schizophrenia and bipolar disorder patients, but not in unipolar depressed patients compared with nonpsychiatric subjects from the Stanley Foundation Neuropathology Consort...

Full description

Saved in:
Bibliographic Details
Published inNeuroreport Vol. 18; no. 1; p. 57
Main Authors Guidotti, Alessandro, Ruzicka, William, Grayson, Dennis R, Veldic, Marin, Pinna, Graziano, Davis, John M, Costa, Erminio
Format Journal Article
LanguageEnglish
Published England 08.01.2007
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Prefrontal cortex (Brodmann's area 9) levels of the methyl donor S-adenosyl methionine were increased by about two-fold in schizophrenia and bipolar disorder patients, but not in unipolar depressed patients compared with nonpsychiatric subjects from the Stanley Foundation Neuropathology Consortium (Bethesda, Maryland, USA). Neither age, brain weight and pH, hemisphere, post-mortem interval, disease onset/duration, nor cumulative dose of fluphenazine affected S-adenosyl methionine content. In schizophrenia and bipolar disorder patients, the increase of S-adenosyl methionine is associated with an overexpression of DNA methyltransferase-1 mRNA in Brodmann's area 9 GABAergic neurons. Hence, the increased expression of S-adenosyl methionine and DNA methyltransferase-1 may contribute to promoter cytosine 5-methylation and to downregulation of the expression of mRNAs encoding for reelin and GAD67 in cortical GABAergic neurons of schizhophrenia and bipolar disorder patients.
AbstractList Prefrontal cortex (Brodmann's area 9) levels of the methyl donor S-adenosyl methionine were increased by about two-fold in schizophrenia and bipolar disorder patients, but not in unipolar depressed patients compared with nonpsychiatric subjects from the Stanley Foundation Neuropathology Consortium (Bethesda, Maryland, USA). Neither age, brain weight and pH, hemisphere, post-mortem interval, disease onset/duration, nor cumulative dose of fluphenazine affected S-adenosyl methionine content. In schizophrenia and bipolar disorder patients, the increase of S-adenosyl methionine is associated with an overexpression of DNA methyltransferase-1 mRNA in Brodmann's area 9 GABAergic neurons. Hence, the increased expression of S-adenosyl methionine and DNA methyltransferase-1 may contribute to promoter cytosine 5-methylation and to downregulation of the expression of mRNAs encoding for reelin and GAD67 in cortical GABAergic neurons of schizhophrenia and bipolar disorder patients.
Author Pinna, Graziano
Grayson, Dennis R
Guidotti, Alessandro
Veldic, Marin
Davis, John M
Costa, Erminio
Ruzicka, William
Author_xml – sequence: 1
  givenname: Alessandro
  surname: Guidotti
  fullname: Guidotti, Alessandro
  organization: Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, Illinois, USA
– sequence: 2
  givenname: William
  surname: Ruzicka
  fullname: Ruzicka, William
– sequence: 3
  givenname: Dennis R
  surname: Grayson
  fullname: Grayson, Dennis R
– sequence: 4
  givenname: Marin
  surname: Veldic
  fullname: Veldic, Marin
– sequence: 5
  givenname: Graziano
  surname: Pinna
  fullname: Pinna, Graziano
– sequence: 6
  givenname: John M
  surname: Davis
  fullname: Davis, John M
– sequence: 7
  givenname: Erminio
  surname: Costa
  fullname: Costa, Erminio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17259861$$D View this record in MEDLINE/PubMed
BookMark eNo1j11LwzAYhXMxcR_6D0T6BzqTN2k-LsfUKYwJVfFyJM1bVmnTkkyx_97hx9WB83AeOHMyCX1AQq4YXTJq1M3brlxSRxlHDprSGmuvJmRGTWFyYWQxJfOU3imlhjJ9TqZMQWG0ZDNSPufWY-jT2GYdHg9NH5qAmQ0-u92tfqqxPUYbUo3RJsxZ1pUn0H9ixK8hYkqnSdaEbEhjdehTky7IWW3bhJd_uSCv93cv64d8-7R5XK-2eQVGslxR4AyYKRwXkkttUHsALWXhCuaUcNYwJypeCSlkLawCX_laIIDRCioOC3L96x0-XId-P8Sms3Hc_5-Db4V5Uos
CitedBy_id crossref_primary_10_1016_j_bbagrm_2008_01_001
crossref_primary_10_1371_journal_pone_0134671
crossref_primary_10_1016_j_neuropharm_2010_12_011
crossref_primary_10_1016_j_pnpbp_2021_110352
crossref_primary_10_1038_s41431_019_0485_3
crossref_primary_10_2217_14622416_9_12_1809
crossref_primary_10_1016_j_schres_2009_03_020
crossref_primary_10_2217_epi_13_22
crossref_primary_10_1016_j_pnpbp_2008_12_015
crossref_primary_10_3389_fncel_2020_00285
crossref_primary_10_1016_j_neubiorev_2016_06_010
crossref_primary_10_1371_journal_pone_0115644
crossref_primary_10_1016_j_phrs_2011_05_026
crossref_primary_10_1016_j_jpsychires_2011_03_015
crossref_primary_10_1007_s11064_008_9718_5
crossref_primary_10_1016_j_brainres_2008_07_074
crossref_primary_10_1016_j_jad_2009_01_031
crossref_primary_10_5498_wjp_v11_i12_1177
crossref_primary_10_3390_brainsci13121704
crossref_primary_10_1586_14737175_9_1_87
crossref_primary_10_3109_01677063_2014_892485
crossref_primary_10_1093_schbul_sbn054
crossref_primary_10_1016_j_neubiorev_2009_10_010
crossref_primary_10_1016_j_neubiorev_2020_03_005
crossref_primary_10_1016_j_tig_2012_04_002
crossref_primary_10_1016_j_schres_2007_09_020
crossref_primary_10_1017_S0954579413000618
crossref_primary_10_3389_fnins_2016_00202
crossref_primary_10_3390_cells10112890
crossref_primary_10_4236_nm_2012_31015
crossref_primary_10_1002_ddr_21345
crossref_primary_10_1016_j_neuropharm_2011_08_010
crossref_primary_10_1038_npp_2012_125
crossref_primary_10_1016_j_pnpbp_2010_08_028
crossref_primary_10_1016_j_neuropharm_2010_10_021
crossref_primary_10_1111_j_2042_7158_2012_01475_x
crossref_primary_10_1016_j_indcrop_2018_07_046
crossref_primary_10_1016_j_nbd_2011_12_008
crossref_primary_10_1152_physrev_00012_2010
crossref_primary_10_1096_fj_201700736RR
crossref_primary_10_1073_pnas_0700529104
crossref_primary_10_4103_1673_5374_219027
crossref_primary_10_1016_j_yhbeh_2010_10_001
crossref_primary_10_2217_epi_09_2
crossref_primary_10_31887_DCNS_2014_16_3_aguidotti
crossref_primary_10_1016_j_biopsych_2008_11_028
crossref_primary_10_1007_s00127_014_0831_2
crossref_primary_10_1016_j_conb_2010_04_007
crossref_primary_10_1017_S1461145710001574
crossref_primary_10_1038_npp_2011_221
crossref_primary_10_1007_s13148_011_0038_2
crossref_primary_10_1371_journal_pone_0144750
crossref_primary_10_1146_annurev_pharmtox_061008_103102
crossref_primary_10_1017_S1461145711001520
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/WNR.0b013e32800fefd7
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 17259861
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: R01MH70855
– fundername: NIMH NIH HHS
  grantid: R01MH71667
– fundername: NIMH NIH HHS
  grantid: R01MH6262A
GroupedDBID ---
-~X
.-D
.Z2
0R~
123
4Q1
5RE
5VS
AAAAV
AAHPQ
AAIQE
AAMTA
AARTV
AAYEP
ABBUW
ABDIG
ABJNI
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXNZ
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFDTB
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
AWKKM
BQLVK
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EIF
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
H0~
HZ~
IKREB
IN~
JG8
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
O9-
OAG
OCUKA
ODA
OL1
OLG
OLV
OLW
OLZ
OPUJH
OPX
ORVUJ
OUVQU
OVD
OVDNE
OWV
OWZ
OXXIT
P2P
RLZ
S4R
S4S
TEORI
V2I
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
ZFV
ZZMQN
ID FETCH-LOGICAL-c2961-702312195b3463689e8d228665b51b74ba91b4c3c4646f4a72dcdf4e229872c32
ISSN 0959-4965
IngestDate Wed Feb 19 01:45:11 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2961-702312195b3463689e8d228665b51b74ba91b4c3c4646f4a72dcdf4e229872c32
PMID 17259861
ParticipantIDs pubmed_primary_17259861
PublicationCentury 2000
PublicationDate 2007-January-8
PublicationDateYYYYMMDD 2007-01-08
PublicationDate_xml – month: 01
  year: 2007
  text: 2007-January-8
  day: 08
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuroreport
PublicationTitleAlternate Neuroreport
PublicationYear 2007
SSID ssj0009018
Score 2.17852
Snippet Prefrontal cortex (Brodmann's area 9) levels of the methyl donor S-adenosyl methionine were increased by about two-fold in schizophrenia and bipolar disorder...
SourceID pubmed
SourceType Index Database
StartPage 57
SubjectTerms Cell Adhesion Molecules, Neuronal - genetics
Cell Adhesion Molecules, Neuronal - metabolism
Chromatography, High Pressure Liquid - methods
Cohort Studies
DNA (Cytosine-5-)-Methyltransferase 1
DNA (Cytosine-5-)-Methyltransferases - genetics
DNA (Cytosine-5-)-Methyltransferases - metabolism
Extracellular Matrix Proteins - genetics
Extracellular Matrix Proteins - metabolism
Gene Expression Regulation - physiology
Glutamate Decarboxylase - genetics
Glutamate Decarboxylase - metabolism
Humans
Isoenzymes - genetics
Isoenzymes - metabolism
Mental Disorders - pathology
Mental Disorders - physiopathology
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Prefrontal Cortex - metabolism
RNA, Messenger - metabolism
S-Adenosylmethionine - metabolism
Serine Endopeptidases - genetics
Serine Endopeptidases - metabolism
Title S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis
URI https://www.ncbi.nlm.nih.gov/pubmed/17259861
Volume 18
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUKSIgLYt-RD9xQIHHcLMeKRQiJHgqF3lC8RIpIC6Itonw94yVJgSCWS1TZUdR4np2Z8ZtnhA5i4SZJ4IcOdyVzaJPDnIsYBCsioqnwOWBGq322g4suvew1e43GyxRraTxiR_yttq7kP1aFNrCrqpL9g2XLh0ID_Ab7whUsDNdf2fjaSYQS-57k-iRonVo12wGn7ZZumuQj7ZnKZ_haOd5hvwMdirUpXy0DVjMdTS3WMBtO-6pat8PsKZQsnXEGUaxhALRydXqK0jsoN23Gbxl_0N6oTeNU7J5kYku7ThWdZljxFG9lLjJuy4asDHiRhQh1FmJq4dTpRKU9X7-ylggyy6TRpP6yehtV4Lt2p0jPEnBnU5mKD7eDDZ762qLgfCl5ee_n3k-a2kXXDJqB6EIdl6pyPIVUs6uzwuUbFQWXcXhc99eU7Kx93KfQRLsoN0to0cYWuGWAsowacrCC5q8se2IVdSq84AovGGyIAS-4Bi9Y4QV_xAvOBrjEyxrqnp_dnFw49kwNh5M48JxQ6f3BV6rJfCUVF8UyEoQo0UPW9FhIWRJ7jHKYpAENUpqERHCRUklIHIWE-2QdzQ4eB3ITYUE5oWkMQ-EyuDuKCZOCq7KWyE-J8LbQhhmN-ycjnHJfjNP2tz07aKFC1y6aS2Gmyj1w-0ZsX1vpHUzJVn0
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=S-adenosyl+methionine+and+DNA+methyltransferase-1+mRNA+overexpression+in+psychosis&rft.jtitle=Neuroreport&rft.au=Guidotti%2C+Alessandro&rft.au=Ruzicka%2C+William&rft.au=Grayson%2C+Dennis+R&rft.au=Veldic%2C+Marin&rft.date=2007-01-08&rft.issn=0959-4965&rft.volume=18&rft.issue=1&rft.spage=57&rft_id=info:doi/10.1097%2FWNR.0b013e32800fefd7&rft_id=info%3Apmid%2F17259861&rft_id=info%3Apmid%2F17259861&rft.externalDocID=17259861
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-4965&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-4965&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-4965&client=summon